Evidence map›Paper›PMID 34684688›Full record

ArticleMolecules (Basel, Switzerland)2021

Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens.

Hiroaki Echigo, Kenji Mishiro, Takeshi Fuchigami, Kazuhiro Shiba, Seigo Kinuya, Kazuma Ogawa

Open access · goldAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. The novel [RSC advances · 2026
    Article
  2. Article
  3. Combination therapy of anEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hiroaki EchigoGraduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Kenji MishiroInstitute for Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0002-5071-7574
Takeshi FuchigamiGraduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Kazuhiro ShibaResearch Center for Experimental Modeling of Human Disease, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8640, Japan.ORCID 0000-0001-7120-0200
Seigo KinuyaDepartment of Nuclear Medicine, Kanazawa University Hospital, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8641, Japan.
Kazuma OgawaGraduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0002-1691-7302
Kanazawa University · JPKanazawa University Hospital · JP

Funding

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan 21H02867Kanazawa University SAKIGAKE project 2020 No grant numberMitani Foundation for Research and Development No grant numberPancreas Research Foundation of Japan No grant number
6 · The paper itself

Abstract

We recently developed

Indexed as

AnimalsCell Line, TumorDimerizationFemaleGlioblastomaHumansIntegrin alphaVbeta3Iodine RadioisotopesIsotope LabelingMiceMice, Inbred BALB CMice, NudeOligopeptidesRadiopharmaceuticalsTissue DistributionXenograft Model Antitumor Assaysarginyl-glycyl-aspartic acidIntegrin alphaVbeta3Iodine-125Iodine-131Iodine RadioisotopesOligopeptidesRadiopharmaceuticalsalpha-particleintegrinRGD peptidetumor

Identifiers

PMID34684688
PMCPMC8539346
OpenAlexW3207404993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.